Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.
复制标题
DOI：
10.1038/sj.bjc.6601242
复制
发表时间：
2003-09-15
影响因子：
8.8
通讯作者：
Dunlop, D J
中科院分区：
文献类型：
--
作者：
Forrest, L M;McMillan, D C;McArdle, C S;Angerson, W J;Dunlop, D J
在不可手术的非小细胞肺癌患者中，基于全身炎症反应和白蛋白风险比（HR）1.70，95% CI 1.23 - 2.35，P=0.001）的评分在预后价值方面与基于分期和体力状态的评分（HR 1.48，95% CI 1.12 - 1.95，P=0.006）相当。前者易于衡量，标准化程度很高。
A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 – 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 – 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.